Cure My Disease

Don't miss your cure!

 Log in / Sign up

New heart procedure could tame irregular heartbeat

NCT ID NCT06106594

Ongoing Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device system that uses pulsed electric fields to treat atrial fibrillation, a common heart rhythm problem. About 300 people with symptomatic, recurrent atrial fibrillation will receive the procedure. The goal is to see if it safely and effectively restores normal heart rhythm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pulsed field ablation using the Volt PFA System
What this could lead to
If successful, this could offer a safer, more effective way to treat atrial fibrillation and reduce symptoms.
What could go wrong
This is a mid-stage study with 300 participants; results may not apply to everyone. Risks include serious complications like stroke or heart damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation paroxysmal atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL ARRHYTHMIA ATRIAL FIBRILLATION PAROXYSMAL ATRIAL FIBRILLATION PERSISTENT ATRIAL FIBRILLATION

Contacts and locations

Locations

  • A. ö. Krankenhaus der Elisabethinen Linz

    Linz, UPR AUS, 4020, Austria

  • AZ Sint Jan

    Bruges, Wflndrs, 8000, Belgium

  • Hospital Universitari i Politècnic La Fe

    Valencia, Valencia, 46026, Spain

  • Monash Health

    Clayton, Victoria, 3168, Australia

  • Nemocnice Na Homolce

    Prague, Cbohmia, 15030, Czechia

  • Royal Adelaide Hospital

    Adelaide, Saustrl, 5000, Australia

  • Royal Melbourne Hospital - City Campus

    Parkville, Victoria, 3050, Australia

  • The Prince Hospital

    Chermside, Queensl, 4032, Australia

  • UMC Utrecht

    Utrecht, Utrecht, 3584 CX, Netherlands

  • UZ Brussel

    Brussels, Brussels Capital, 1090, Belgium

  • Universitätsklinikum Schleswig-Holstein - Campus Lübeck

    Lübeck, Schlesw, 23562, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.